Use Cases Bucket 1

Clinical Trials

Stakeholders

Sponsors, Investigators, Regulators, and Patients.

Background

86% of clinical trials don’t achieve the patient enrollment goals on time and about 19% of clinical trials get terminated due to insufficient patient subjects.

Objective

To reduce the time taken to enroll patients using a blockchain process automation solution.

Solution

The blockchain solution automates patient enrollment in clinical trials. Sponsors can send a matching request to the smart contract which in turn notifies the qualified patients. The smart contacts qualify the patients using the inclusion/exclusion criteria set in the protocols. Thus, the blockchain solution helps connect sponsors with patients anonymously. Based on the patient geography, the sponsor can select the clinical sites for trial. Once the study is approved by the authority, the patient is incentivized for participation.

Benefits

Faster completion of clinical trials.

Stakeholders

Sponsors, Investigators, Regulators, CROs, Physicians, and Patients

Background:

Clinical reproducibility is the ability of a clinical trial to bring about the same desired output every time it is fed with the same data inputs. But close to 80% of medical studies are non-reproducible meaning they don’t provide the same output at all given times. Suffice to say that the data integrity is lost at some point in the process.

Objective

To achieve data integrity and eliminate falsification of data using a data traceability solution.

Solution

A clinical trial is subjected to an extensive protocol that is approved by a regulatory authority. The trails pass through 5 phases. Across the phases, the raw data collected from patients in the form of surveys, interviews, and lab results, is recorded in the immutable ledger. The blockchain ledger contains the actual data, proof of data existence (e.g., a consent that has been signed by the patient), and metadata (e.g., protocol version, statistical analysis plan). Timestamping, time-sequencing, and smart contracting features ensure data provenance at every step in the clinical trial.

Benefits

High research quality and lower cost of drug development.

Stakeholders

Sponsors, Investigators, Regulators, CROs, Physicians, and Patients

Background

Twofold challenges in conducting faster and efficient clinical trials: 1 – patient recruitment 2. Trial reproducibility. Put together, these challenges entail huge costs for the sponsors and affect drug delivery timelines.

Objective

Streamline clinical trials through end-to-end process automation and data traceability solutions.

Solution

The solution combines the features of automated patient enrollment and trial reproducibility solutions. The patient is enrolled faster, incentivized to participate, and has full control over their identities and consent forms. The blockchain ledger ensures clinical data integrity through timestamping, time-sequencing, and smart contracting features.

Benefits

High research quality, lower cost of drug development, faster-to market drugs, improved patient privacy.

Use Cases Bucket 2

Drug Supply Chain

Stakeholders

Regulators, Manufacturers, Physicians, and Patients

Background

For every pharmaceutical drug, billions of papers are printed, folded into a carton, and distributed on a global scale. Printing paper leaflets is costly and comes with an environmental impact. It is also inefficient to do content revisions on paper especially when the product goes through periodic updates that need to be instantly reflected in the leaflets.

Objective

A blockchain-enabled electronic solution that will give customers instant access to the latest product information.

Solution

The customer will scan a 2D QR code printed on the drug package that will help them instantly receive the latest information concerning the product. Once the product information document is created by the manufacturers, it goes to ‘review & approval’ by the health authorities. The document is immutable to edits. And hence every change is tracked, and accordingly, new versions of the document are made available. Once approved, manufacturers can publish the approved version which is available in real-time to patients and physicians.

Benefits

Production line efficiencies, eliminates the costs associated with printing, improved access to critical information, better information clarity, and safe consumption of the drug.

Stakeholders

Regulators, Manufacturers, Physicians, and Patients

Background

Counterfeit medicines cost manufacturers billions, create a bad reputation, and pose health hazards to patients including death. Around 10% of medical products circulated in low-income countries are either substandard or falsified. In developed countries, fake drugs trade continues to be on the rise. Existing anti-counterfeit checks stop only 50% of illegal drugs.

Objective

A blockchain-enabled solution that will enable stakeholders instantly confirm the authenticity of a medical product.

Solution

The stakeholders will be able to scan a 2D matrix printed on the drug package. The QR code will encode product details such as the GTIN, batch number, and serialization number. If the product is not authentic, then the blockchain application will return with the message that the serial number or the batch number could not be identified or is unknown to the manufacturer.

Benefits

Reduction in revenue loss from counterfeits, high-quality generic drugs, brand reputation intact, and improved patient health and safety.

Stakeholders

Manufacturers, distributors

Background

Recalls happen when there are defects in manufacturing, mislabeling, or probable contamination that occurred during transit. In such cases, initiating recalls by alerting distributors spread across geographies tends to be a slow and manual process.

Objective

Optimizing the backward supply chain so as to reduce the cost and time taken associated with product recalls by the manufacturer.

Solution

The application instantly notifies the corresponding distributor in case of any product recalls by the manufacturer. The product info, production date, and the number of units pertaining to individual batches are stored on the blockchain ledger and shared with the concerned stakeholders. The unique tokens provided to each batch help the stakeholders track its movement in the supply chain. In the case of a recall situation, the manufacturer can use the tokens to instantly target only those batches that need to be recalled upon which the distributor can augment corrective action.

Use Cases Bucket 1

Clinical Trials

Stakeholders

Sponsors, Investigators, Regulators, and Patients.

Background

86% of clinical trials don’t achieve the patient enrollment goals on time and about 19% of clinical trials get terminated due to insufficient patient subjects.

Objective

To reduce the time taken to enroll patients using a blockchain process automation solution.

Solution

The blockchain solution automates patient enrollment in clinical trials. Sponsors can send a matching request to the smart contract which in turn notifies the qualified patients. The smart contacts qualify the patients using the inclusion/exclusion criteria set in the protocols. Thus, the blockchain solution helps connect sponsors with patients anonymously. Based on the patient geography, the sponsor can select the clinical sites for trial. Once the study is approved by the authority, the patient is incentivized for participation.

Benefits

Faster completion of clinical trials.

Stakeholders

Sponsors, Investigators, Regulators, CROs, Physicians, and Patients

Background

Clinical reproducibility is the ability of a clinical trial to bring about the same desired output every time it is fed with the same data inputs. But close to 80% of medical studies are non-reproducible meaning they don’t provide the same output at all given times. Suffice to say that the data integrity is lost at some point in the process.

Objective

To achieve data integrity and eliminate falsification of data using a data traceability solution.

Solution

A clinical trial is subjected to an extensive protocol that is approved by a regulatory authority. The trails pass through 5 phases. Across the phases, the raw data collected from patients in the form of surveys, interviews, and lab results, is recorded in the immutable ledger. The blockchain ledger contains the actual data, proof of data existence (e.g., a consent that has been signed by the patient), and metadata (e.g., protocol version, statistical analysis plan). Timestamping, time-sequencing, and smart contracting features ensure data provenance at every step in the clinical trial.

Benefits

High research quality and lower cost of drug development.

Stakeholders

Sponsors, Investigators, Regulators, CROs, Physicians, and Patients

Background

Twofold challenges in conducting faster and efficient clinical trials: 1 – patient recruitment 2. Trial reproducibility. Put together, these challenges entail huge costs for the sponsors and affect drug delivery timelines.

Objective

Streamline clinical trials through end-to-end process automation and data traceability solutions.

Solution

The solution combines the features of automated patient enrollment and trial reproducibility solutions. The patient is enrolled faster, incentivized to participate, and has full control over their identities and consent forms. The blockchain ledger ensures clinical data integrity through timestamping, time-sequencing, and smart contracting features.

Benefits

High research quality, lower cost of drug development, faster-to market drugs, improved patient privacy.

Use Cases Bucket 2

Drug Supply Chain

Stakeholders

Regulators, Manufacturers, Physicians, and Patients

Background

For every pharmaceutical drug, billions of papers are printed, folded into a carton, and distributed on a global scale. Printing paper leaflets is costly and comes with an environmental impact. It is also inefficient to do content revisions on paper especially when the product goes through periodic updates that need to be instantly reflected in the leaflets.

Objective

A blockchain-enabled electronic solution that will give customers instant access to the latest product information.

Solution

The customer will scan a 2D QR code printed on the drug package that will help them instantly receive the latest information concerning the product. Once the product information document is created by the manufacturers, it goes to ‘review & approval’ by the health authorities. The document is immutable to edits. And hence every change is tracked, and accordingly, new versions of the document are made available. Once approved, manufacturers can publish the approved version which is available in real-time to patients and physicians.

Benefits

Production line efficiencies, eliminates the costs associated with printing, improved access to critical information, better information clarity, and safe consumption of the drug.

Stakeholders

Regulators, Manufacturers, Physicians, and Patients

Background

Counterfeit medicines cost manufacturers billions, create a bad reputation, and pose health hazards to patients including death. Around 10% of medical products circulated in low-income countries are either substandard or falsified. In developed countries, fake drugs trade continues to be on the rise. Existing anti-counterfeit checks stop only 50% of illegal drugs.

Objective

A blockchain-enabled solution that will enable stakeholders instantly confirm the authenticity of a medical product.

Solution

The stakeholders will be able to scan a 2D matrix printed on the drug package. The QR code will encode product details such as the GTIN, batch number, and serialization number. If the product is not authentic, then the blockchain application will return with the message that the serial number or the batch number could not be identified or is unknown to the manufacturer.

Benefits

Reduction in revenue loss from counterfeits, high-quality generic drugs, brand reputation intact, and improved patient health and safety.

Stakeholders

Manufacturers, distributors

Background

Recalls happen when there are defects in manufacturing, mislabeling, or probable contamination that occurred during transit. In such cases, initiating recalls by alerting distributors spread across geographies tends to be a slow and manual process.

Objective

Optimizing the backward supply chain so as to reduce the cost and time taken associated with product recalls by the manufacturer.

Solution

The application instantly notifies the corresponding distributor in case of any product recalls by the manufacturer. The product info, production date, and the number of units pertaining to individual batches are stored on the blockchain ledger and shared with the concerned stakeholders. The unique tokens provided to each batch help the stakeholders track its movement in the supply chain. In the case of a recall situation, the manufacturer can use the tokens to instantly target only those batches that need to be recalled upon which the distributor can augment corrective action.

Set up Your Blockchain Network in Minutes

Blockedge is an infrastructure automation platform to build and scale enterprise blockchains faster.

Instant deployment of blockchain nodes

Automated network management

Health monitoring of nodes 24*7

Proactive alerts on failure detection

Accelerators to integrate d’Apps with existing IT

Co-create your blockchain application with industry partners

Enterprise blockchain is in fact a multi-enterprise technology well-positioned to solve industry-wide problems. But questions such as who owns the consortia, or who owns the network, prevent organizations from participating in blockchain consortiums.

Blockedge offers a collaborative multi-enterprise platform that enables organizations to participate in blockchain consortium projects, protected by anti-trust frameworks and managed by neutral third-party infrastructure automation systems.

Consortia-ready environment

A Hi-trust certified infrastructure that ensures data privacy of all participant organizations through in-built non-competitive governance frameworks.

Rapid prototyping
studio

Blockedge gives you the ability to previsualize your application and demonstrate proof of value to stakeholders. dApplets is a rapid prototyping studio to create, iterate, and finalize blockchain use cases.

Zero-Code
deployment

The UI-driven platform needs no coding prerequisites to run and manage your blockchain networks.

Multi-Cloud and Multi-Chain Support

You can get your dApps up and running in minutes. Set up nodes, create smart contracts, and customize from a wide choice of cloud providers and blockchain networks in a few clicks.

Hassle-Free Solution Integration

Blockedge’s proprietary integration accelerator, Glu enables a frictionless data passage between present enterprise systems and blockchain applications via APL calls and XML schemas.

Automated Network Management

Bring down managed services expense by 1/10th of the original cost. Get advanced dashboards to view, assess, and receive proactive alerts concerning the health, and performance of all the nodes in your network.

Schedule a Demo
Is Your Organization ready for Blockchain?

Find out Your blockchain readiness score.

Business vs. Problem

People vs. Technology



Cost vs. Benefits

Company vs. Law

Is Your Organization ready for Blockchain?

Find out Your blockchain readiness score.

The 5-minute survey will assess your organization’s readiness against 4 factors mentioned below.